Showing results (231-240 of 2,672) with videos related to

Sort By:
Pageof 268
Exploration of Targeted Anti-Tumor Therapy|July 5, 2024
Antibody-drug conjugates combinations in cancer treatmentGiulia Pretelli, Kleida Mati, Lucia Motta, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Nanocomposites Based on Spin-Crossover Nanoparticles and Silica-Coated Gold Nanorods: A Nonlinear Optical StudyEleni Zygouri, Aristeidis Stathis, Stelios Couris, et al.
Critical Reviews in Oncology/Hematology|November 20, 2021
Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatmentSofia Genta, Federica Martorana, Anastasios Stathis, et al.
Pharmacology & Therapeutics|April 20, 2020
An overview on anti-tubulin agents for the treatment of lymphoma patientsMarilia Barreca, Anastasios Stathis, Paola Barraja, et al.
International Journal of Molecular Sciences|February 9, 2020
Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?Chiara Tarantelli, Antonio Lupia, Anastasios Stathis, et al.
Fungal Genetics and Biology : FG & B|March 14, 2007
The proline permease of Aspergillus nidulans: functional replacement of the native cysteine residues and properties of a cysteine-less transporterPanagiota Kafasla, Demetra Bouzarelou, Stathis Frillingos, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 10, 2012
E-CYMHS: an expansion of a child and youth telepsychiatry model in QueenslandJennylee Wood, Stephen Stathis, Anthony Smith, et al.
The Journal of Biological Chemistry|November 2, 2006
Cysteine-scanning analysis of the nucleobase-ascorbate transporter signature motif in YgfO permease of Escherichia coli: Gln-324 and Asn-325 are essential, and Ile-329-Val-339 form an alpha-helixPanayiota Karatza, Panayiotis Panos, Ekaterini Georgopoulou, et al.
The Journal of Biological Chemistry|April 22, 2010
Purine substrate recognition by the nucleobase-ascorbate transporter signature motif in the YgfO xanthine permease: ASN-325 binds and ALA-323 senses substrateEkaterini Georgopoulou, George Mermelekas, Ekaterini Karena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical reviewG Iacoboni, E Zucca, M Ghielmini, et al.
Pageof 268